The Alexandra General Hospital is a General hospital in central Athens, Greece. It was established in 1954, initially as a Maternity Hospital and later as a Maternity & Obstetrics - Gynecological Hospital. It is located at Vassilisis Sofias avenue in the center of Athens.

There are 350 beds in Alexandra General Hospital of Athens.

During the past decade, Alexandra General Hospital of Athens conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Alexandra General Hospital of Athens" are "Multiple Myeloma" (4 trials), "Relapsed or Refractory Multiple Myeloma" (2 trials) and "Smoldering Multiple Myeloma" (1 trials). Many other conditions were trialed in "Alexandra General Hospital of Athens" in a lesser frequency.

Most popular intervention types in "Alexandra General Hospital of Athens" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (4 trials), "Daratumumab" (3 trials), "Pomalidomide" (3 trials), "Teclistamab" (3 trials) and "Bortezomib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alexandra General Hospital of Athens" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Alexandra General Hospital of Athens". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Alexandra General Hospital of Athens, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Alexandra General Hospital of Athens, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".